small molecule oral cgrp receptor antagonists Search Results


90
Kissei Pharmaceutical oral, non-peptide small molecule gonadotrophin releasing hormone (gnrh) receptor antagonist

Oral, Non Peptide Small Molecule Gonadotrophin Releasing Hormone (Gnrh) Receptor Antagonist, supplied by Kissei Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oral, non-peptide small molecule gonadotrophin releasing hormone (gnrh) receptor antagonist/product/Kissei Pharmaceutical
Average 90 stars, based on 1 article reviews
oral, non-peptide small molecule gonadotrophin releasing hormone (gnrh) receptor antagonist - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Allergan small molecule oral cgrp receptor antagonists

Small Molecule Oral Cgrp Receptor Antagonists, supplied by Allergan, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small molecule oral cgrp receptor antagonists/product/Allergan
Average 90 stars, based on 1 article reviews
small molecule oral cgrp receptor antagonists - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Journal: Drugs

Article Title: Linzagolix: First Approval

doi: 10.1007/s40265-022-01753-9

Figure Lengend Snippet:

Article Snippet: An oral, non-peptide small molecule gonadotrophin releasing hormone (GnRH) receptor antagonist being developed by Kissei Pharmaceutical for the treatment of uterine leiomyoma and endometriosis.

Techniques:

Features and properties of Linzagolix

Journal: Drugs

Article Title: Linzagolix: First Approval

doi: 10.1007/s40265-022-01753-9

Figure Lengend Snippet: Features and properties of Linzagolix

Article Snippet: An oral, non-peptide small molecule gonadotrophin releasing hormone (GnRH) receptor antagonist being developed by Kissei Pharmaceutical for the treatment of uterine leiomyoma and endometriosis.

Techniques: Drug discovery, Clinical Proteomics